Guangdong Marubi Biotechnology (603983.SH) plans to jointly increase capital by 60 million yuan with affiliated party Wang Kaihui for Qingdao Maoda.

Guangdong Marubi Biotechnology (603983.SH) announced that the company plans to jointly increase the capital of Qingdao Maoda Equity Investment Partnership Enterprise (Limited Partnership) ("Qingdao Maoda") by 60 million yuan with related party Wang Kaihui. The company, as the original limited partner, will increase its subscribed capital by 57 million yuan, reducing its share from 99.9000% to 98.0625%. New limited partner Wang Kaihui will subscribe 3 million yuan, holding a 1.8750% share. Beijing Zhongheng Jingding Investment Management Co., Ltd. (renamed Xiamen Zhongheng Jingding Private Equity Fund Management Co., Ltd. on August 1, 2023, referred to as "Zhongheng Jingding") will maintain its subscribed capital and its share will decrease from 0.1000% to 0.0625%.